HarbourVest Takes $21 Million Stake in Generate Biomedicines
The investment firm acquired 1.72 million shares of GENB in Q1, marking its first position in the post-IPO drug developer. HarbourVest Partners disclosed a new $21.03 million stake in Generate Biomedicines (NASDAQ:GENB) on May 15, 2026, purchasing 1,722,210 shares in the f